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Abstract. The biosynthesis, intracellular  transport, 
and surface expression of the/3 cell glucose trans- 
porter GLUI2 was investigated in isolated islets and 
insulinoma cells.  Using a trypsin sensitivity assay to 
measure cell surface expression,  we determined that: 
(a) greater than 95 % of GLUT2 was expressed on the 
plasma membrane;  (b) GLUT2 did not recycle in in- 
tracellular vesicles; and (c) after trypsin treatment, 
reexpression of the intact transporter occurred with a 
tl/2 of --7 h. 
Kinetics of intracellular  transport of GLUT2 was in- 
vestigated in pulse-labeling experiments combined with 
glycosidase treatment and the trypsin sensitivity assay. 
We determined that transport from the endoplasmic 
reticulum to the trans-Golgi network (TGN) occurred 
with a tl/2 of 15 min and that transport from the TGN 
to the plasma membrane required a  similar half-time. 
When added at the start of a pulse-labeling experi- 
ment, brefeldin A prevented exit of GLUT2 from the 
endoplasmic reticulum.  When the transporter was first 
accumulated in the TGN during a  15-min period of 
chase, but not following a low temperature (22°C) in- 
cubation, addition of brefeldin A  (BFA) prevented sub- 
sequent surface expression of the transporter.  This in- 
dicated that brefeldin A prevented GLUT2 exit from 
the TGN by acting at a  site proximal to the 22°C 
block. Together,  these data demonstrate that GLUT2 
surface expression in B cells is via the constitutive 
pathway,  that transport can be blocked by BFA at two 
distinct steps and that once on the surface, GLUT2 
does not recycle in intracellular  vesicles. 
LUT2 is  a  facilitated  diffusion  glucose transporter 
characterized by a  restricted tissue distribution:  it 
is present in the  sinusoidal  membrane of hepato- 
cytes, the basolateral membrane of intestine and kidney epi- 
thelial cells, and in pancreatic/3 cells (Thorens,  1992). Func- 
tionally, GLUT2 differs from the other facilitated  diffusion 
glucose transporter isoforms by a relatively  high Michaelis 
constant  for  glucose  (Kin  =  •17  mM)  (Johnson  et  al., 
1990a).  The expression of GLUq2 in pancreatic  ~ cells has 
been suggested to be important for the normal glucose sensi- 
tivity of these cells (Unger,  1991; Thorens,  1992).  Impor- 
tantly, the expression  of this transporter is reduced or sup- 
pressed in glucose-unresponsive/3 cells from diabetic  rats 
and mice, a phenomenon that may participate in the/3 cell 
dysfunctions  associated  with  diabetes  (Johnson  et  al., 
1990b; Orci et al.,  1990; Thorens et al.,  1990, 1992). De- 
creased expression of GLUI2 in diabetes is observed only 
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in/~ cells while there is no change or rather an elevation of 
its expression  in the liver,  intestine,  and kidney. While in 
most situations  decreased expression  of GLUI2 correlates 
with a decrease in its mRNA levels, decreased GLUT2 ex- 
pression in dexamethasone-treated  rats has been reported to 
be controlled at the translational  or posttranslational  level 
(Ogawa et al.,  1992).  Despite its important role in/3 cell 
physiology  and  its  regulated  expression  in  diabetes,  a 
detailed  knowledge  of GLUT2  biosynthesis,  intracellular 
transport,  and surface expression  is still lacking. 
Pancreatic  B cells have both a constitutive  and regulated 
pathway  (Kelly, 1985)  for  protein  surface  expression  or 
secretion.  Insulin  biosynthesis,  targeting  to the secretory 
pathway, and regulated secretion by exocytosis have been ex- 
tensively studied (Steiner,  1977). In particular,  exit of proin- 
sulin from the TGN towards  the regulated  pathway and its 
parallel  conversion  into  insulin  has  been  well  described 
(Orci et al.,  1985;  1987).  Comparatively little  is known, 
however, about the biosynthesis of endogenous  ~ cell pro- 
teins following the constitutive pathway. Infection of islet cell 
monolayers with influenza or vesicular stomatitis viruses re- 
suited  in polarized cell surface budding of viral particles. 
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membrane proteins in a  polarized way  (Lombardi et al., 
1985).  Localization  of GLU'I2  to  microvilli present  on 
lateral membranes of/~ cells was another indication of the 
polarity of the/3 cell surface (Orci et al.,  1989). 
Here we studied GLUI2 surface expression in pancreatic 
/~ cells using a protease sensitivity assay, and we investigated 
its  intracellular transport by biosynthetic labeling  experi- 
ments using the INS-1 insulinoma cell line. We demonstrated 
that GLUI2 is permanently expressed at the cell surface and 
does not recycle in intraceUular vesicles. We followed GLU'I2 
intracellular transport to the cell surface via the constitutive 
pathway, and we showed that brefeldin A (BFA) ~  blocked this 
transport at two different steps: at the exit of the endoplasmic 
reticulum, as already extensively described for a number of 
proteins, and also at the exit from the TGN before reaching 
the plasma membrane. 
Materials and Methods 
Materials 
Tissue culture medium and complements were from GIBCO/BRL  (Gai- 
thersburg, MD). Collagenase CLS4 was from Worthington Biochem Corp. 
(Freehold,  NJ),  Ficoll 400 dl from Sigma lmmunochemicals  (St. Louis, 
MO),  [35S]methionine from  Amersham  Corp.  (Arlington  Heights,  IL), 
neuraminidase from vibrio cholerae from Boehringer Corp. Mannheim (In- 
dianapolis,  IN)  and endo-~-glycosaminidase-H  from Boehringer  Mann- 
heim Corp. or New England Biolabs (Beverly, MA). BFA was a gift from 
Drs. R6mer and Rissi, Sandoz Preclinical Research, Basel, Switzerland. 
L-l-tusylamide-2-phenylethyl-chloromethyl  ketone (TPCK)-treated trypsin 
and  chymotrypsin  were  purchased  from Sigma  Immunochemicals  and 
elastase from Boehringer Mannheim Corp. 
Islet Isolation and Cell Culture 
Pancreatic islets were isolated from Sprague-Dawiey rats weighing 190- 
230 g by collagenase digestion of the pancreas followed by separation on 
discontinuous Ficoll gradients,  according to the method of Ootoh et al. 
(1987). Before the experiments, islets were kept at a concentration of 5-10 
islets per ml in culture medium:(RPMI 1640, 10 mM Hepes, pH 7.4, 2 mM 
glutamine,  1 mM pyrnvate, 50 #M ~-mercaptoethanol,  and 10% FCS for 
at least 18 h to allow them to recover from the isolation procedure. The insu- 
linoma cell line INS-1 (Asfari et al., 1992) (passages 100-120) was kept in 
the same culture medium. Incubations were run at 37°C and in a humidified 
atmosphere in the presence of 5% CO:. 
Antibodies,  Western Blot Analysis and 
Trypsin Digestion 
Antipeptide antibodies to GLUI2 have been described previously (Thorens 
et al., 1988). Briefly, the carboxy-terminal antibody was raised against a 
peptide corresponding to amino acids 513-522 of rat GLUT2 and the anti- 
body to the first exoplasmic loop of rat GLU'I2 was against a peptide corre- 
sponding to amino acids 47-60. For Western blot analysis of GLLrI2, islets 
or INS-1 cells were lysed in a buffer containing 80 mM Tris-HC1, pH 6.8, 
5% SDS, 5 mM EDTA, 0.2 mM N-ethyl maieimide (NEM),  1 mM PMSE 
The lysates were sonicated for 30 s in the cup ofa sonicator (Branson Ultra- 
sonics Corp., Danbury, CT), separated by electrophoresis on SDS-contain- 
ing 7.5% polyacrylamide gels, transferred to nitrocellulose filters. Detec- 
tion of GLU'I2  was performed as previously described  (Thorens  et al., 
1988) except that we used the enhanced chemiluminescence detection sys- 
tem (ECL)  from Amersham  Corp.  with  the primary  antibodies diluted 
1:2,000. For trypsin digestion, islets or INS-1 cells were washed three times 
in I-IBSS containing 20 mM Hepes, pH 7.4. Incubations were in the same 
buffer with 20 #g/ml of TPCK-treated trypsin for 30 min at 4°C,  except 
1. Abbreviations used in this paper: ~-COE coatomer protein; BFA, brefel- 
din A. 
when otherwise stated. Islets were incubated by groups of  20-50 in 500 #1 
of the above buffer and INS-1 cells in 60-ram tissue culture dishes in 2 ml 
of the same solution. The digestions were stopped by three washes in the 
presence of 1-mM  PMSF before preparation of  cell lysates for Western blot 
analysis or GLUT2 immunoprecipitatiun. 
Biosynthetic Labeling and Immunoprecipitation 
For biosynthetic labeling, INS4 cells were grown in 60-mm tissue culture 
dishes, washed three times in I-IBSS, and incubated in 1 rnl of RPMI 1640 
culture medium lacking methionine, plus the complement described above 
and 10% dialyzed calf serum. Cells were preincubated for 30 min at 37°C, 
before addition of [35Slmethionine  at a concentration of 100 #Ci/ml.  In all 
experiments, the pulse labeling was for 5 rain at 37°C. The cells were then 
quickly transferred to ice, the medium removed, and the cells washed with 
ice-cold I-IBSS. The cells were then either kept on ice before further pro- 
cessing or they received prewarmed medium containing 2 mM cold methio- 
nine before being returned to 37°C for different periods of  chase. When BFA 
was added,  it was present at  10 #g/nil and was diluted from a 10-mg/ml 
stock made up in absolute ethanol and stored at -200C. At the end of the 
experiments, cells were washed three times in HBSS, scraped into a conical 
15-ml tube, centrifuged, and resuspended in 1 ml of 0.25 M sucrose, 20 
mM Hepes, pH 7.4, containing 0.1-0.2 U of aprotinin. Cells were kept on 
ice  for  10  min before homogenization with  the A  pestle  of a  Dounce 
homogenizer (Kontes Glass Co., Vineland, NJ). The number of strokes was 
adjusted  so that about 80%  of the cells were broken,  as determined  by 
trypan blue staining. The homogenate was centrifuged for 10 min at 1,000 
rpm in a tabletop centrifuge (Beckman Instrs. Inc., Fullterton,  CA), and 
the membrane present in the supernatant were pelleted at 75,000 rpm for 
15 win at 4°C in the TL120 rotor of a Beckman Instrs., Inc. Optima TLX 
ultracentrifuge. Pellets were dissolved in 100 #1 of a phosphate buffered so- 
lution (1.5 mM KI-I2PO4, 8 mM NazHPO4, 2H20, 2.7 mM KCI, 137 mM 
NaCI) containing 1% SDS, 5 raM EDTA, 1 mM PMSF, and 0.2 mM NEM 
from a fresh stock. The solubilized membrane pellet was then diluted in 400 
#1 of  the same phosphate buffered solution containing the same protease in- 
hibitors and 1.25 % Triton X-100. Two 5-#1 aliquots of  the solubilized mem- 
brane preparations  were precipitated  with trichloroacetic acid  for deter- 
ruination of the incorporated  radioactivity.  Immunoprecipitations  were 
performed on identical amounts of incorporated radioactivity with 0.5/~1 
of both the carboxy-terminal and exoplasmic loop antibodies, for 16-18 h 
at 4°C.  Immunocomplexes were collected with protein A-Sepharose and 
washed once with each of the following solutions: (a) 20 mM Tris-HC1, 
pH 8.1, 1M NaCI,  1% Nonidet P-40, 1 mM EDTA, 1% deoxycholate; (b) 
20  mM Tris-HC1,  pH  8.1,  1 M  KC1, 0.1% Triton  X-100; (c) 20  raM 
Tris-HC1, 0.1 M NaCI,  1% Triton X-100, 0.5% SDS, 0.5% deoxycholate; 
and (d) 20 mM Tris-HC1, pH 8.1, 0.2% Nonidet P-40. The protein A-Seph- 
arose beads were then resuspended in Laemmli sample buffer (Laemmli, 
1970) containing 5% SDS and loaded on 7.5% SDS-polyacrylamide gels. 
The gels were then treated for fluorography with diphenyl oxazol in glacial 
acetic acid, washed in water, dried, and exposed to Kodak X-AR 5 films 
at  -70°C for 3-7 d. 
Glycosidase Treatments 
Endo-/~-glycosaminidase-H  treaanent  was performed  on immunoprecipi- 
rated GLUT2 as follows. After immunoprecipitation and washing of  the im- 
munocomplexes, a final wash was performed in 50 mM Na citrate, pH 5.5. 
The immunooomplexes were then incubated in the same citrate buffer with 
the enzyme for 18 h at 37°C before addition of Laemmli sample buffer and 
separation by gel eleetrophoresis.  For treatment with neuraminidase, the 
immunocomplexes were washed as above, washed in digestion buffer (10 
mM Tris-HCl, pH 6.0, 150 mM NaC1, 10 mM CaCI2), and then incubated 
in 500 #1 of  the same buffer with 0.1 U of  enzyme for 30 min at 37°C before 
addition of Laemmli buffer and analysis by gel electrophoresis. 
Results 
Trypsin Sensitivity Assay 
In freshly isolated islets GLUT2, most of the time, appears 
as multiple bands,  the highest migrating with an apparent 
molecular mass of 62 kD (for example see Thorens et al., 
1992) (data not shown). After an overnight period in culture 
medium GLUT2 is, however, detected as a single ,,o62-kD 
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age by trypsin. Islets incubated overnight in culture medium were 
exposed to the indicated concentrations of  trypsin at 4°C for 30 min 
before analysis of GLUT2 by immunoblotting. Total conversion of 
GLUT2 in a cleaved form is achieved with 10/~g/ml. 
band.  This  suggested  that  GLUT2  was  proteotypically 
degraded during the islet isolation procedure. To test the pro- 
teolytic sensitivity of GLUT2, pancreatic islets were pre- 
pared and kept overnight in culture medium and then ex- 
posed to trypsin,  chymotrypsin and  elastase present at a 
concentration of 100 t~g/ml and for 30 ruin at 37°C. Each of 
these  enzymes  increased  the  electrophoretic mobility  of 
GLUI2 by ,,04 kD (not shown). To further test the sensitivity 
of GLUT2 to trypsin, islets were subjected to different con- 
centrations of trypsin at 4°C for 30 rain. As shown in Fig. 1, 
complete conversion of intact GLUI2 into the faster migrat- 
ing form was achieved with trypsin concentration as low as 
10 t~g/ml, revealing the high sensitivity of GLUT2 to trypsin 
digestion. Since trypsin quantitatively cleaved GLUT2, even 
at 4°C, a temperature at which no membrane recycling pro- 
ceeds, this result further indicated that GLUT2 was constitu- 
tively expressed at the beta cell surface and was not present 
in intracellular vesicles. 
To determine the site of trypsin cleavage, we used two dif- 
ferent antipeptide antibodies. One was directed against the 
carboxy-terminal amino acids of GLUT2 (amino acids 513- 
522), the other against amino acids 47-60 which are located 
in the first exoplasmic loop, just before the glycosylated argi- 
nine (position 62) (see Fig. 2). The faster migrating form of 
Figure 2.  Determination of the trypsin cleavage site. Islets incu- 
bated overnight in culture medium or INS-1 insulinoma cells were 
treated with 20/~g/ml trypsin at 4°C for 30 min, lysed, and GLUI2 
detected  by  immunoblotting  with  an  antibody  specific for the 
carboxy-terminal end of GLUT2 (C-term) or specific for amino 
acids 45-62 present in the first exoplasmic loop of GLUT2 (Exo). 
The immunoblots indicate that both the intact and cleaved forms 
of the transporter are recognized by the carboxy-terminal antibody 
but that the cleaved form has lost the epitope recognized by the exo- 
loop-specific antibody. On the fight part of the figure, a scheme of 
GLUT2 describes the regions of the transporter recognized by the 
two antibodies (heavy segments), the N-glycosylation site (N) and 
the sites of proteolytic cleavage by trypsin (arrows). 
Figure 3. Time course of GLUT2 surface reexpression after trypsin 
cleavage. (,4) Islets incubated overnight in culture medium were 
treated or not (C) with tryspin at 4°C for 30 rain and either lysed 
directly  or returned  to  370C for the indicated periods  of time 
(hours). Islets were then lysed and GLUT2 analyzed by immuno- 
blotting. (B) Densitometry scanning analysis of the kinetics of dis- 
appearance of cleaved GLUT2 (tin  =  2 h) and reexpression of 
GLUT2 on/~ cells membrane (tu2 =  7 h). This experiment is rep- 
resentative of five experiments. 
GLUI2 generated by trypsin digestion was detected only 
by the carboxy-terminal antibody but not by the antibody to 
the exoplasmic loop, demonstrating that this epitope was re- 
moved by the protease digestion. Indentical results were ob- 
tained with GLUT2 expressed on the cell surface of either 
pancreatic/3 cells or INS-1 rat insuiinoma cells (Fig. 2). The 
N-linked  oligosaccharide  is  however  still  present  on the 
cleaved form of the transporter as the deglycosylated form 
of noncleaved GLUT2 (see below) migrated with a  faster 
mobility than the cleaved form. Therefore, protease diges- 
tion of GLU'I2 took place in the exoplasmic loop, on the 
amino terminal side of the N-glycosylation site. The amino 
acid sequence of this region indeed shows the presence of 
multiple potential cleavage sites for trypsin, chymotrypsin, 
or elastase (Thorens et al.,  1988). 
Surface Reexpression of GLUT2 in Pancreatic/3 Cells 
The trypsin sensitivity assay was used to determine the half- 
time  of surface reexpression of GLUT2 after proteolytic 
cleavage of the transporter.  Pancreatic islets  were treated 
with trypsin at 4°C and then transferred back to 37°C for 
different periods of time before cell lysis and Western blot 
analysis of GLUT2 with the carboxy-terminal antibody. The 
disappearance of the cleaved form occurred with a  t~a of 
2-3 h and surface reexpression of GLUT2 at the cell surface 
was completed with a tla of about 6-7 h  (Fig. 3 A and B). 
The faster rate of disappearance of cleaved GLUT2 com- 
pared to the rate of reexpression suggested that once the 
structure of the transporter was modified, this induced a fast 
degradation of the protein. 
Biosynthetic Experiments 
For biosynthetic studies, we used the rat insulinoma cell line 
INS-1 which, unlike most insulinoma cell lines described so 
far, expresses a level of GLLrI2 comparable to that of/3 cells 
and no GLUT1, even at passages >100 (this paper and data 
not shown).  The use of pancreatic/3 cells for biosynthetic 
studies would require a very high number of isolated islets 
which would be extremely difficult to obtain to perform such 
experiments. Pulse labeling with [35S]methionine was, in all 
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were pulse-labeled  for 5  min and then chased for the indicated 
periods of time (rain) before immunoprecipiation of GLUT2. The 
immunoprecipitates were then incubated in the presence or absence 
of neuraminidase.  The increased  mobility of the mature form of 
GLUT2 upon neuraminidase  treatment indicated that this form had 
already acquired sialic  acid, an event taking place in the TGN. 
cated (Roth et al.,  1985). To assess whether the mature form 
of GLUT2 was already expressed on the surface, INS-1 cells 
were  pulse-labeled  for 5  min  and  subsequently  chased  in 
cold medium for increasing periods of time.  At the end of 
the chase periods, cells were incubated on ice in the presence 
or absence of trypsin for 30 min. After washings in the pres- 
Figure 4. Biosynthetic labeling of  GLUT2 in INS-1 cells. (A) Insuli- 
noma cells were pulse labeled  for 5 min (5P) with [35S]methionine 
and then chased for the indicated periods of time (min) in the pres- 
ence of excess cold methionine.  GLUT2 was then immunoprecipi- 
tated and separated on 7.5 % polyacrylamide gels. The lower arrow- 
head shows the position of core-glycosylated GLUT2 (55 kD), the 
upper  arrowhead  shows  the  position  of the  fully  glycosylated 
GLUT2 (62 kD). (B) Same experiment  as in A but the immunopre- 
cipitates were treated  with or without endo-/~-glycosaminidase  H 
(endo-H). The coreglycosylated form of GLUT2 (upper left arrow) 
is converted into a faster migrating band (molecular mass = 53 kD) 
(lower left arrow) by glycosidase treatment.  The mature form (right 
arrow)  is insensitive  to the enzyme. 
experiments,  for  5  min  and  was  followed  by  increasing 
periods of chase in different conditions. Fig. 4 A shows that 
pulse-labeled GLUT2 appeared as a single band of molecu- 
lar mass 55 kD which progressively disappeared during the 
chase period and at the same time, a mature form of GLUT2 
appeared with a molecular mass of 62 kD.  That the 55-kD 
form of GLUT2 corresponded to a  core-glycosylated form 
of GLUT2 was shown by endo-/3-glycosaminidase-H treat- 
ment of the immunoprecipitated transporter  (Fig. 4 B).  As 
long as a 55-kD form was detectable,  it was sensitive to the 
endoglycosidase while the mature form which appeared pro- 
gressively during the chase period was resistant.  To deter- 
mine whether the 62-kD form of GLUT2 was modified up 
to the point of sialic  acid addition,  we performed similar 
pulse-chase experiments and determined the neuraminidase 
sensitivity of the transporter.  As soon as the mature, 62-kD 
form of GLUT2 appeared, it was sensitive to neuraminidase 
treatment,  as detected by an increase in the electrophoretic 
mobility after enzyme treatment (Fig. 5). This indicated that 
the mature  form of GLUT2 detected  in these experiments 
was transported to the TGN where sialylstransferase  is lo- 
Figure 6.  Time course of GLUT2 transport from the TGN to the 
plasma membrane.  (A) INS-1 cells  were pulse-labeled  for 5 min 
(5P) and chased in cold medium for the indicated  periods of time 
(min). At the end of the chase periods, the cells were treated or not 
with trypsin at 4°C for 30 min before cell lysis and GLUT2 immu- 
noprecipitation.  Arrowhead on the left: coreglycosylated form of 
GLUT2; upper right arrowhead:  mature form of GLUT2; lower 
right arrowhead: trypsin-cleaved form of surface-expressed GLUT2. 
Immunoprecipitation efficiency  of trypsin-cleaved  GLUT2 is  re- 
duced compared to immunoprecipitation of intact GLUT2 because 
the epitope recognized by the exoplasmic loop antibody (one of the 
two antibodies  used for immunoprecipitation)  is lost after trypsin 
digestion.  (B) Densitometry scanning analysis of disappearance  of 
coreglycosylated GLUT2, of appearance of the mature transporter 
and of its cell surface expression as assessed by acquisition  of tryp- 
sin sensitivity. The mature form appeared with a 6/2 of 15 min and 
the tl/2 of 15 min and the tl/2 for surface expression  was 30 min in- 
dicating that GLUT2 transport from the TGN to the cell surface was 
achieved  with  a tt/2 of 15 min. 
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immunoprecipitated for separation by gel electrophoresis. 
GLUT2 sensitivity to trypsin, as assessed by a  shift in its 
electrophoretic mobility,  was observed with a  delay com- 
pared to appearance of the mature form (Fig. 6 A). Quantita- 
tive  analysis  by  densitometric  scanning  of the  autoradio- 
grams (Fig.  6  B)  indicated  that the half-time for GLUT2 
transport from the endoplasmic reticulum to the TGN was 
15 min and that expression of the mature (sialylated) form 
of GLUT2 at the plasma membrane took place with a half- 
time of 30 min. 
Brefeldin A  Inhibition  of lntraceUular  Transport 
Altogether, the above experiments showed that GLUT2 in- 
tracellular  transport to  the  plasma membrane follows the 
constitutive pathway of/3 cells.  Moreover, our pulse-chase 
experiments indicated that biosynthetically labeled GLUT2 
could be transiently accumulated in the TGN before being 
expressed at the cell surface. The amount of GLUT2 in the 
TGN at the steady state represents only a fraction of the total 
pool of GLUT2:GLUT2 residence time in the TGN is •15 
min while from the reexpression studies (Fig.  3) it takes a 
tl/2 of about 7 h for refilling the surface GLU'I2 pool. There- 
fore at any given time,  no more than a  few percent of the 
transporter is in the TGN. By immunofluorescence micros- 
copy, no internal GLUT2 could be demonstrated (not shown). 
As the TGN is where the separation between the constitu- 
tive and regulated pathways occurs (Grifliths et al.,  1986), 
we were interested in determining whether the exit from this 
compartment towards the plasma membrane via the constitu- 
tive pathway could be functionally distinguished  from the 
regulated pathway. INS-1 cells were pulse labeled and chased 
for 30 min in the presence of BFA. This led to GLUI2 being 
retained  as  a  55-kD  form which  did  not undergo  further 
maturation  to  the  62-kD  form  (Fig.  7)  or  only  partial 
modification with longer time of chase in the presence of 
BFA (see Fig.  8).  These observations were consistent with 
a  number of published works (Misumi et al.,  1986;  Doms 
et al.,  1989;  Lippincott-Schwartz et al.,  1989)  showing a 
partial and a slower rate of processing of proteins retained 
in the endoplasmic reticulum in the presence of BFA.  We 
Figure  7.  Brefeldin A blocks 
GLUT2  endoplasmic  reticu- 
lure to Golgi transport.  INS-1 
cells were pulse-labeled for 5 
min (P) and chased for 30 min 
in the presence or absence of 
10/zg/ml BFA. In the absence 
of  BFA, GLUT2  was  con- 
verted  in  the  mature  form 
within  the  chase  period.  In 
contrast,  in  the  presence  of 
BFA, no maturation of GLUI2 
was observed,  indicating that 
GLUT2 had  not  been trans- 
ported to the Golgi complex. 
The lower two bands detected 
below coreglycosylated  GLUT2 
were  sometimes  observed  in 
pulse-chase  experiments  (see 
also Fig. 4 A). 
Figure 8. Brefeldin A prevents 
GLUT2  transport  from  the 
TGN  to  the  plasma  mem- 
brane. INS-1 cells were pulse- 
labeled  for 5  min  (5P)  and 
then chased for 15 min to al- 
low accumulation of ~50% of 
GLUT2 in the TGN. BFA was 
then added at 10 #g/ml and the 
cells chased for an additional 
45  min.  In  the  absence  of 
BFA, GLUT2 becomes sensi- 
tive to trypsin,  indicating that 
it  was  expressed  at  the  cell 
surface.  In  the  presence  of 
BFA, the mature form of GLUT2 never became trypsin sensitive, 
indicating that it was retained intracellularly. The appearance of  the 
immature form of GLUT2 as multiple bands in the presence of BFA 
may be due to partial processing of  the oligosaccharide chain conse- 
quent to the mixing of the Golgi and ER compartments. 
next pulse labeled the ceils for 5 min and chased them for 
15 min, a  condition that allows the transient accumulation 
of a  fraction of GLUT2  in  the  TGN,  as  described  above 
(Figs. 7 and 8). BFA was then added and the cells chased for 
an additional 45 min before treatment of the cells in the pres- 
ence or absence of trypsin at 4°C. In cells incubated in the 
absence of BFA,  a  complete cleavage of GLUT2 was ob- 
served (Fig. 8) while the presence of BFA in the chase period 
prevented the acquisition of trypsin sensitivity by GLUq2. 
A similar observation was made when the chase in the pres- 
ence of BFA was for 2 h instead of  45 min (not shown). These 
observations indicated that a BFA-sensitive step was present 
in  the  transport of this  protein between the  TGN and the 
plasma membrane. We further showed that the block by BFA 
was reversible since washing the cells free from the drug fol- 
lowed by incubation of ceUs at 37°C for 1 h, led to complete 
recovery of GLUT2 trypsin sensitivity (Fig.  9). 
A low temperature (20°C) block for intracellular transport 
of viral glycoproteins from the TGN to the plasma mem- 
brane has been described (Marlin et al., 1983; Saraste et al., 
1984;  Griffiths et al.,  1985).  To determine where the BFA 
block was localized relative to this temperature block, we 
Figure 9. BFA block in trans- 
port  from  TGN  to  plasma 
membrane is reversible. INS-1 
cells were pulse-labeled for 5 
min, chased for 15 min, and 
exposed to BFA for an addi- 
tional 45 min. This prevented 
surface expression of GLUT2 
as assessed  by trypsin  sensi- 
tivity  (lanes 1 and 2).  Some 
cells  were  then  washed  free 
from BFA and the incubation 
was  continued  for  an  addi- 
tional  hour  before  treatment 
with  or  without  trypsin  and 
immunoprecipitation of GLUT2. GLUT2 sensitivity to trypsin was 
fully restored in the absence of BFA, indicating a complete reversi- 
bility of the block. 
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imal to the  low temperature 
block. INS-1 cells were pulse- 
labeled for 5 min and chased 
for  15  min  to  accumulate 
GLUT2 in the TGN. The cells 
were then incubated for 2 h at 
22°C and treated with or with- 
out  trypsin.  In  these  condi- 
tions no surface expression of 
GLU'I~ could be measured (lanes 1 and 2) but all of the GLUT2 
was in a mature form. Cells were then exposed (lanes 3 and 4) or 
not (lanes 5 and 6) to BFA for 15 min before the end of the low 
temperature incubation and further incubated for 2 h at 37°C and 
then treated (lanes 3 and 5) or not (lanes 4 and 6) with trypsin. 
In the absence or presence of  BFA, GLUT2 acquired complete tryp- 
sin sensitivity to trypsin, indicating that the BFA block is proximal 
to the low temperature block. 
pulse-labeled the cells for 5 min, allowed them to accumu- 
late GLUT2 in the TGN during a  15-min chase period at 
37°C, and then chased them for an additional 2 h at 22°C. 
The cells were then treated or not with trypsin and GLUT2 
analyzed. Some other cells were returned to 37°C in the ab- 
sence or presence of BFA. The drug-treated cells received 
BFA 15 rain before the end of the 22°C incubation to ensure 
that the drug was fully active at the time of the transfer to 
37°C. At the end of the chase period, cells were treated or 
not with trypsin before cell lysis and GLUT2 analysis (Fig. 
10). After the 2-h period at 22°C, the 62-kD form of GLUT2 
was completely resistant to trypsin, indicating that the low 
temperature block was allowing an efficient retention of the 
transporter within the TGN. Shift of the cells to 37°C in the 
presence or absence of BFA led to a complete acquisition of 
trypsin sensitivity, indicating a complete reversibility of the 
cold block. This suggested that the BFA block for GLUT2 
exit from the TGN was proximal to the low temperature 
block. 
Discussion 
In the present report, we describe the biosynthesis, intracel- 
lular transport, and surface expression of GLUT2, a/3 cell 
membrane protein with a  major physiological role in the 
control  of  glucose-induced  insulin  secretion.  The  main 
findings of the present paper are as follows: (a) GLUT2 is 
constitutively expressed at the cell surface in pancreatic islet 
B cells and in the insulinoma cell line INS-l; (b) there is no 
recycling of the transporter in intracellular vesicles; (c) after 
trypsin  cleavage of GLUT2,  the  cleaved form is  rapidly 
degraded with a t~ of ~2 h and reexpression of GLUT2 is 
completed with a  tt~ of ~7 h;  (d) GLUT2 is transported 
from the endoplasmic reticulum to the TGN with a rapid ki- 
netics and its exit from the TGN to the cell surface via the 
constitutive pathway occurs with a similar half-time; and (e) 
brefeldin A blocks intracellular transport of GLUT2 at two 
distinct  steps:  exit out of the endoplasmic  reticulum and 
transport from the TGN to the plasma membrane. 
The high sensitivity of GLUT2's first extracellular loop to 
proteolytic digestion by trypsin, chymotrypsin, and elastase 
may be due to its length of 64 amino acids in GLUT2 com- 
pared to '~32 amino acids in the other transporters isoforms 
(Thorens et al., 1988; Bell et al., 1990). This protease semi- 
tivity allowed us to develop an assay to measure GLU'I2 sur- 
face expression. At low temperature (4°C) when membrane 
recycling is prevented, the transporter could be quantita- 
tively cleaved into a  faster migrating form. This indicated 
that GLUT2 was constitutively expressed at the cell surface 
and that no intracellular pool of this transporter was present 
in/5 cells. An identical situation was found in the INS-1 insu- 
linoma cells. The surface expression of GLUT2 in these en- 
docrine cells contrasts with the expression of GLUT4 (and 
also GLUT1) in insulin-sensitive tissues. Indeed, in particu- 
lar for GLUT4, most of the transporter is present in intracel- 
lular vesicles at the resting state and the transporter is trans- 
located to the cell surface only after insulin  binds  to its 
receptor on the plasma membrane of adipocytes or muscle 
cells (reviewed in Birnbaum,  1992). 
After trypsin digestion, the cleaved transporter was very 
rapidly degraded with a t~,2 of ,~2 h.  Surface reexpression 
of newly synthesized GLUT2 was completed with a slower 
kinetics (t~ ~7 h). Since at the steady state the kinetics of 
reexpression equals the kinetics of degradation, the present 
protocol for measuring GLU12 reexpression permits us to 
measure the turnover of the transporter on the plasma mem- 
brane.  This protocol should  also  be  useful to  determine 
whether this parameter is modified in conditions of altered 
GLUT2 expression, such as in islets from diabetic animals. 
Our  data  demonstrated  that  intracellular  transport  of 
GLUT2 to the/3 cell surface follows the constitutive pathway. 
Transport  from  the  endoplasmic  reticulum  to  the  TGN 
proceeded with a half-time of ,,o15 rain and surface expres- 
sion from the TGN occurred with a similar half-time of '~15 
rain. Interestingly, we showed that BFA, a fungi metabolite, 
in  addition  to  blocking  endoplasmic  reticulum  to  Golgi 
transport, could also block GLUT2 exit from the TGN. 
BFA has  been shown to  interfere with the anterograde 
transport of proteins from the endoplasmic reticulum to the 
Golgi complex but to allow the retrograde transport of Golgi 
resident proteins including glycosyltransferases from the c/s-, 
medial-,  and trans-Golgi stacks to the endoplasmic retic- 
ulum (Doms et al., 1989; Lippincott-Schwartz et al.,  1989; 
Lippincott-Schwartz et al.,  1990;  Klausner et al.,  1992). 
This block of enterograde transport in the presence of con- 
tinuous  retrograde transport induces mixing of the Golgi 
complex with the endoplasmic reticulnm. This could explain 
the partial processing of GLUT2 observed at longer periods 
of chase in the presence of BFA.  However, no retrograde 
transport to the endoplasmic reticulum of TGN-specific pro- 
teins such as sialyltransferase (Chege et al., 1990) or TGN38 
(Reaves  et al.,  1992)  could be  observed.  In  the  case of 
TGN38, BFA has instead been shown to induce the relocal- 
ization of this protein close to the microtubnle organizing 
center, indicating that the TGN collapsed close to this struc- 
ture. These and related observations (Lippincott-Schwartz et 
al.,  1991) have led to the conclusion that the TGN and the 
bulk of  the Golgi complex were separate membrane systems. 
In addition, TGN in the presence of BFA forms mixed tu- 
bular  structures  with  the  endosomal  system  (Lippincott- 
Schwartz  et  al.,  1991;  Wood  et  al.,  1992).  This  mixed 
TGN/endosome compartment has, however, been shown to 
be able to allow continued internalization and recycling of 
membrane receptors to the cell surface. 
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Figure 11. Schematic representation of GLUT2 intracellular trans- 
port through the constitutive pathway of/~ cells. Transport from the 
rough endoplasmic reticulum to the TGN occurs with a tta of 15 
win. At the level of  the TGN, GLUt2 follows  the constitutive path- 
way and reaches the cell surface with a tu2 of 15 win. Endoplas- 
mic reticulum to Golgi transport of GLUT2 is blocked by BFA as 
is the exit out of  the TGN towards the plasma membrane. The block 
by BFA is at a step proximal to the low temperature block (20"C 
block). The BFA action on TGN exit of GLUT2 suggests the in- 
volvement of/3-COP-containing  coatomers in the constitutive ex- 
pression of the transporter to the cell surface. This contrasts with 
proinsulln targetting to secretory granules by budding of Golgi- 
derived, clathrin-coated vesicles. These vesicles are also the site of 
proinsulin conversion into insulin.  (See text for additional dis- 
cussion.) 
In that context, it was interesting to observe that GLUT2 
exit from the TGN could also be blocked by BFA. This ob- 
servation was possible because we could transiently accumu- 
late newly biosynthesized GLUT2 in that structure and test 
the effect of this drug on the subsequent surface expression 
using the trypsin sensitivity assay.  Functionally, BFA inter- 
feres with intracellular transport mechanisms by preventing 
the attachment to Golgi membranes of a small GTP-binding 
protein, the ADP-ribosylation factor (ARF),  which is re- 
quired for subsequent binding of the coatomer protein (B- 
COP) (Donaldson et al., 1992; Helms et al., 1992). ~-COP 
has been found associated with different parts of the Golgi 
complex and with vesicles from the TGN (Duden et al., 
1991), suggesting that the transport steps from the TGN were 
mediated by ~-COP-coated vesicles. The observed block of 
GLUT2 exit from this structure in the presence of  BFA there- 
fore suggests that this transport step is carried out by vesicles 
requiring B-COP to bud from the TGN. Interestingly, when 
GLUq2 was first allowed to accumulate in the TGN at 22"C 
the addition of BFA before returning the cells to 37°C did 
not lead to a block of surface expression. This suggests that 
the low temperature block for exit from the TGN may be dis- 
tal to the BFA block of vesicle budding. 
In pancreatic/3 cells, the TGN is also the structure from 
which condensing insulin granules are formed. These are 
generated from budding, clathrin-coated, vesicles in which 
conversion of proinsulin to insulin is initiated (Orci et al., 
1985,  1987).  In the exocrine pancreas BFA was shown to 
have no effect on transport of proenzyme from Golgi com- 
plex to  zymogen granules  (Hendricks et al.,  1992).  Al- 
though, to our knowledge, no such evidence has yet been 
presented for pro/insulin segregation into condensing vacu- 
oles, it is probable that clathrin-coated vesicle budding from 
the  TGN towards  the  regulated  secretory pathway is  not 
impeded by BFA. Therefore, our study illustrates that in/3 
cells, exit from the TGN towards the constitutive pathway is 
mediated by different transport mechanisms than regulated 
secretion. 
In summary, as depicted in Fig. 11, we have demonstrated 
that GLUT2 was transported to the/3 cell surface via the con- 
stitutive pathway. This transport took place with a relatively 
fast kinetics.  BFA blocked this  transport at two different 
steps: at the exit from the endoplasmic reticulum and also 
at the exit from the TGN at a site proximal to the low temper- 
amre block. Once at the cell surface, GLUT2 resided perma- 
nently at the cell surface and did not recycle in intracellular 
vesicles. Cleavage of GLUT2 in the first extracellular do- 
main with trypsin induced its rapid degradation and also al- 
lowed us to determine the kinetics with which surface reex- 
pression of the intact transporter took place.  The present 
description of the biosynthetic pathway for GLUT2 expres- 
sion may permit a better understanding of the regulated ex- 
pression of this transporter in glucose-unresponsive/3 cells. 
In particular, in situations in which GLUT2 decreased ex- 
pression may result from translational or posttranslational 
alteration in its expression, as recently reported by Ogawa 
et al. in dexamethasone-induced diabetic rats (Ogawa et al., 
1992). 
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